Dr Desmond Yip

Honorary Associate
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

Telephone +61 2 61442220

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Yip, D., Karapetis, C., Strickland, A., Steer, C., Goldstein, D. (2006). Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 3, CD002093-CD002093. [More Information]
  • Tan, T., Stevenson, B., Yip, D. (2006). Docetaxel-induced nasal septal perforation. Internal Medicine Journal, 36(7), 471-2. [More Information]
  • Steer, C., Chrystal, K., Cheong, K., Galani, E., Marx, G., Strickland, A., Yip, D., Lofts, F., Gallagher, C., Thomas, H., et al (2006). Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study. Gynecologic Oncology, 103(2), 439-445. [More Information]
  • Clarke, S., Boyer, M., Millward, M., Underhill, C., Moylan, E., Yip, D., White, S., Childs, A., Beale, P., Latz, J., et al (2005). A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Lung Cancer, 49(3), 401-412. [More Information]
  • Lim, L., Gibbs, P., Yip, D., Shapiro, J., Dowling, R., Smith, D., Little, A., Bailey, W., Liechtenstein, M. (2005). A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer, 5, 132. [More Information]
  • Yip, D., Goldstein, D. (2005). Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer. Cancer Treatment Reviews, 31(3), 236-41. [More Information]
  • Davis, A., Craft, P., Yip, D. (2005). Australian Patterns of Practice Survey in the ADjuvant Systemic Treatment of Early Breast Cancer. Asia-Pacific Journal of Clinical Oncology, 1(1), 25-33.
  • Underhill, C., Hui, R., Links, M., Hawson, G., Chern, B., Yip, D., Blackwell, T., Crombie, C., Boyer, M. (2005). Phase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLC. Lung Cancer, 49(Sup.2), S272-S273.
  • Lim, L., Gibbs, P., Yip, D., Shapiro, J., Dowling, R., Smith, D., Little, A., Bailey, W., Liechtenstein, M. (2005). Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies. Internal Medicine Journal, 35(4), 222-227. [More Information]
  • Grimpen, F., Yip, D., McArthur, G., Waring, P., Goldstein, D., Loughrey, M., Beshay, V., Chong, G. (2005). Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour. Lancet Oncology, 6(9), 724-7. [More Information]
  • Hughes, B., Yip, D., Chao, M., Gibbs, P., Carroll, S., Goldstein, D., Burmeister, B., Karapetis, C. (2004). Audit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience. ANZ Journal of Surgery, 74(11), 951-956.
  • Hughes, B., Yip, D., Goldstein, D., Waring, P., Beshay, V., Chong, G. (2004). Cerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report. BMC Cancer, 4(1), 74-80.
  • Gibbs, P., Chao, M., Jones, I., Yip, D. (2004). Evidence Supports Adjuvant Radiotherapy In Selected Patients With Rectal Cancer. ANZ Journal of Surgery, 74(3), 152-157.
  • Chua, Y., Steer, C., Yip, D. (2004). Recent Advances In Management Of Small-Cell Lung Cancer. Cancer Treatment Reviews, 30(6), 521-543. [More Information]
  • Steer, C., Yip, D. (2002). Symptom palliation in advanced oesophageal cancer. Current Therapeutics: Australia's journal of disease management and drug treatment, 44(3), 33-35.
  • Yip, D., Craft, P. (2001). Colorectal carcinoma: current issues in management. Current Therapeutics: Australia's journal of disease management and drug treatment, July, 45-50.
  • Yip, D., Gorddard,, N. (2001). Treating lung cancer in older patients. Expert Review of Anticancer Therapy, 1, 30-33.
  • Rangan, A., Ahern, V., Yip, D., Boyages, J. (2000). Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy. ANZ Journal of Surgery, 70, 649-655.

2006

  • Yip, D., Karapetis, C., Strickland, A., Steer, C., Goldstein, D. (2006). Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 3, CD002093-CD002093. [More Information]
  • Tan, T., Stevenson, B., Yip, D. (2006). Docetaxel-induced nasal septal perforation. Internal Medicine Journal, 36(7), 471-2. [More Information]
  • Steer, C., Chrystal, K., Cheong, K., Galani, E., Marx, G., Strickland, A., Yip, D., Lofts, F., Gallagher, C., Thomas, H., et al (2006). Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study. Gynecologic Oncology, 103(2), 439-445. [More Information]

2005

  • Clarke, S., Boyer, M., Millward, M., Underhill, C., Moylan, E., Yip, D., White, S., Childs, A., Beale, P., Latz, J., et al (2005). A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Lung Cancer, 49(3), 401-412. [More Information]
  • Lim, L., Gibbs, P., Yip, D., Shapiro, J., Dowling, R., Smith, D., Little, A., Bailey, W., Liechtenstein, M. (2005). A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer, 5, 132. [More Information]
  • Yip, D., Goldstein, D. (2005). Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer. Cancer Treatment Reviews, 31(3), 236-41. [More Information]
  • Davis, A., Craft, P., Yip, D. (2005). Australian Patterns of Practice Survey in the ADjuvant Systemic Treatment of Early Breast Cancer. Asia-Pacific Journal of Clinical Oncology, 1(1), 25-33.
  • Underhill, C., Hui, R., Links, M., Hawson, G., Chern, B., Yip, D., Blackwell, T., Crombie, C., Boyer, M. (2005). Phase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLC. Lung Cancer, 49(Sup.2), S272-S273.
  • Lim, L., Gibbs, P., Yip, D., Shapiro, J., Dowling, R., Smith, D., Little, A., Bailey, W., Liechtenstein, M. (2005). Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies. Internal Medicine Journal, 35(4), 222-227. [More Information]
  • Grimpen, F., Yip, D., McArthur, G., Waring, P., Goldstein, D., Loughrey, M., Beshay, V., Chong, G. (2005). Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour. Lancet Oncology, 6(9), 724-7. [More Information]

2004

  • Hughes, B., Yip, D., Chao, M., Gibbs, P., Carroll, S., Goldstein, D., Burmeister, B., Karapetis, C. (2004). Audit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience. ANZ Journal of Surgery, 74(11), 951-956.
  • Hughes, B., Yip, D., Goldstein, D., Waring, P., Beshay, V., Chong, G. (2004). Cerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report. BMC Cancer, 4(1), 74-80.
  • Gibbs, P., Chao, M., Jones, I., Yip, D. (2004). Evidence Supports Adjuvant Radiotherapy In Selected Patients With Rectal Cancer. ANZ Journal of Surgery, 74(3), 152-157.
  • Chua, Y., Steer, C., Yip, D. (2004). Recent Advances In Management Of Small-Cell Lung Cancer. Cancer Treatment Reviews, 30(6), 521-543. [More Information]

2002

  • Steer, C., Yip, D. (2002). Symptom palliation in advanced oesophageal cancer. Current Therapeutics: Australia's journal of disease management and drug treatment, 44(3), 33-35.

2001

  • Yip, D., Craft, P. (2001). Colorectal carcinoma: current issues in management. Current Therapeutics: Australia's journal of disease management and drug treatment, July, 45-50.
  • Yip, D., Gorddard,, N. (2001). Treating lung cancer in older patients. Expert Review of Anticancer Therapy, 1, 30-33.

2000

  • Rangan, A., Ahern, V., Yip, D., Boyages, J. (2000). Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy. ANZ Journal of Surgery, 70, 649-655.

To update your profile click here. For support on your academic profile contact .